Drawing for RESPONSEDX: MELANOMA

USPTO serial 85330476

RESPONSEDX: MELANOMA

Reviewed by CopyMark Law Group

Reg. 4207164Status 710
Filing date
Status date
Registration date
Sep 11, 2012
Examiner
STOIDES, KATHERINE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with RESPONSEDX: MELANOMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Shannon Marie McKeon

Shannon Marie McKeon Dykema Gossett PLLC1300 I Street, N.W.Suite 300Washington, DC 20005

Goods and services

ClassDescriptionStatusFirst use
042Medical research; scientific research and development, medical and scientific research consulting; drug discovery analysis services; pharmaceutical drug development analysis services; diagnostic testing services, namely, providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; providing scientific research information in the field of pharmaceuticals and clinical trials; providing an on-line computer database for others in the fields of medicine development, pharmacogenomics in the nature of scientific research in the field of genetics, scientific research information in the field of cancer diagnosis, scientific research information in the field of clinical trial design and scientific research information in the field of biotechnology; product development services for others in the biomedical, genomics, pharmacogenomics, diagnostic, clinical trial design and biotechnology fieldsSECTION 8 - CANCELLEDMay 1, 2011
044Providing medical diagnostic testing services for diagnostic and prognostic purposes; and providing medical informationSECTION 8 - CANCELLEDMay 1, 2011

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 12, 2019C8..CANCELLED SEC. 8 (6-YR)—
Sep 11, 2017REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 29, 2017ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Aug 3, 2016ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 11, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 8, 2012SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 7, 2012REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Aug 7, 2012CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 20, 2012SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 13, 2012AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 28, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 28, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 18, 2012IUAFUSE AMENDMENT FILED—
Jun 18, 2012EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 27, 2011NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 1, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 1, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 26, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 25, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 19, 2011XAECEXAMINER'S AMENDMENT ENTERED—
Sep 19, 2011ALIEASSIGNED TO LIE—
Sep 19, 2011GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 19, 2011GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 19, 2011CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 10, 2011DOCKASSIGNED TO EXAMINER—
Jun 2, 2011MPMKNOTICE OF PSEUDO MARK MAILED—
Jun 1, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 28, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance